ArticleAnnals of translational medicine2019

Renin-angiotensin inhibitors were associated with improving outcomes of hepatocellular carcinoma with primary hypertension after hepatectomy.

Long-Hai Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.